The results of the KEGG pathway enrichment analysis suggest that multiple pathways and mechanisms are involved in the action of HXS against liver fibrosis, including the hepatitis B pathway, PI3K-AKT signaling pathway, and MAPK signaling pathway (Figure 3c). Here, AKT1 is linked to hepatitis B virus infection.